Filter
2001
Filtered Results: 2001
Text search:
hiv
drug
resistance
Featured
Recommendations
214
New Publications
578
Language
Document type
No document type
1335
Guidelines
246
Studies & Reports
230
Manuals
62
Strategic & Response Plan
50
Fact sheets
32
Training Material
27
Situation Updates
11
Infographics
7
Videos
1
Countries / Regions
India
98
South Africa
69
Kenya
59
Western and Central Europe
57
Tanzania
44
Ethiopia
44
Eastern Europe
42
Uganda
39
Global
38
Zambia
37
Nepal
34
Nigeria
33
Malawi
31
Africa
28
Liberia
27
Ghana
26
Sierra Leone
26
Bangladesh
24
Rwanda
23
Asia
23
Namibia
23
Lesotho
22
Philippines
20
Myanmar / Burma
20
Cambodia
19
Zimbabwe
18
Latin America and the Carribbean
18
Ukraine
17
Russia
14
South–East Asia Region
13
Botswana
13
Indonesia
13
Senegal
12
Mozambique
10
Cameroon
8
Albania
8
Eswatini/ Swaziland
8
Colombia
7
Burkina Faso
7
Thailand
6
Congo, Democratic Republic of
6
Argentina
6
Pakistan
6
Venezuela
5
Germany
5
Georgia
5
West and Central Africa
4
Middle East and North Africa
4
East and Southern Africa
4
Vietnam
4
North Macedonia
3
Tajikistan
3
Benin
3
Estonia
3
Guinea
3
Haiti
3
Jordan
3
Eastern Europe and Central Asia
3
El Salvador
2
China
2
Syria
2
Iran
2
Laos
2
Armenia
2
Western Pacific Region
2
Lebanon
2
Papua New Guinea
2
Moldova
2
Sudan
2
Central African Republic
2
Bhutan
2
Somalia
2
Switzerland
1
Timor Leste/ East Timor
1
Turkey
1
Gambia
1
Kazakhstan
1
Afghanistan
1
Peru
1
Morocco
1
Qatar
1
USA
1
Saudi Arabia
1
Paraguay
1
North America
1
Gabon
1
Uruguay
1
Turkmenistan
1
Tunisia
1
Côte d’Ivoire / Ivory Coast
1
Brazil
1
Sri Lanka
1
Romania
1
Greece
1
Mali
1
South Sudan
1
Iraq
1
Ecuador
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
771
Clinical Guidelines
225
Women & Child Health
65
Public Health
64
Key Resources
46
Capacity Building
24
Pharmacy & Technologies
23
Annual Report MEDBOX
1
Toolboxes
TB
455
HIV
345
AMR
145
Mental Health
46
Pharmacy
44
NTDs
42
COVID-19
37
Caregiver
34
Rapid Response
28
Refugee
26
Ebola & Marburg
23
Global Health Education
19
Polio
16
Health Financing Toolbox
14
Planetary Health
12
NCDs
11
Conflict
9
Cholera
8
Disability
5
Natural Hazards
4
Zika
2
Specific Hazards
1
Social Ethics
1
The HIV drug resistance report 2021 summarizes findings from 38 countries that had finalized the surveys by the time of this report and shared data with WHO.
Pretreatment HIVDR to non-nucleoside reverse-transcriptase inhibitors (NNRTI) can affect more than 10% of adults starting therapy and is fo...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i...
HIV drug resistance , Users Manual
December 2017
This study aimed to understand the patterns of HIV drug resistance in pregnant women in Mozambique. This might help in tailoring optimal regimens for prevention of mother to child transmission of HIV (pMTCT) and antenatal care.
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it ...
The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the availability of quality-assured HIV genotyping laboratory services producing comparable and reliable ...
Guidelines
HIV drug resistance
July 2017
Module 10
Testing providers
July 2017
Module 10: Testing providers. This module is for people who provide testing services at PrEP sites and laboratories. It offers guidance in selecting testing services, including screening of individuals before PrEP is initiated and monitoring while they ar...
WHO’s antiretroviral treatment (ART) clinic-based acquired drug resistance survey method yields robust estimates of HIV viral suppression and acquired HIV drug resistance in adults, children and adolescents taking both dolutegravir and non-dolutegravir based regimens.
Results are used to inform A...
This concept note describes the methods used to assess the prevalence of any HIVDR and HIVDR by PMTCT exposure among children less than 18 months of age using remnant dried blood spot specimens from early infant diagnosis over a 12-month period
2014
Addendum to meeting report: Regional consultation on HIV epidemiologic information in Latin America and the Caribbean
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant ...
